We are live on
!
Find out more
ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
20 hedge funds and large institutions have $57.8M invested in Enzymotec Ltd in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
5% more funds holding
Funds holding: 19 → 20 (+1)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
11% less capital invested
Capital invested by funds: $64.9M → $57.8M (-$7.04M)
Holders
20
Holders Change
+1
Holders Change %
+5.26%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AP
Alydar Partners
Boston,
Massachusetts
|
+$441K |
| 2 |
Goldman Sachs
New York
|
+$401K |
| 3 |
Renaissance Technologies
New York
|
+$383K |
| 4 |
VAM
Visium Asset Management
New York
|
+$248K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$138K |
Top Sellers
| 1 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
-$5.13M |
| 2 |
D.E. Shaw & Co
New York
|
-$268K |
| 3 |
Millennium Management
New York
|
-$176K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$94.8K |
| 5 |
Morgan Stanley
New York
|
-$77.1K |
